RNS Number:3296U
Hikma Pharmaceuticals Plc
03 April 2007




                    Hikma Pharmaceuticals PLC - LTIP Awards

LONDON, 3 April 2007: Hikma Pharmaceuticals PLC (LSE: HIK) (DIFX: HIK) announces
that the Remuneration Committee has made the following awards under the Hikma
Pharmaceuticals PLC 2005 Long-Term Incentive Plan (the "LTIP") to Persons
Discharging Managerial Responsibility ("PDMRs") of the Company.

Awards were made on 2 April 2007 at a price of #3.87 per ordinary share as
follows:-

Name of PDMR         Number of LTIP Shares

Bassam Kanaan        30,000
Nabil Rizk           30,000
Taghreed Al-Shunnar  25,000
Majda Labadi         25,000
Gabriel Kalisse      25,000
Mike Raya            25,000

The shares subject to the LTIP awards will only be released to the participants
in three years time, subject to their continued employment and the satisfaction
of the comparative Total Shareholder Return ("TSR") performance target.
Participants will only receive the full benefit of their share incentives if TSR
performance against the Comparator Group is at least at the upper quartile.

                                    - ENDS -
Enquiries:

Hikma Pharmaceuticals PLC

Henry Knowles             +44 20 7399 2760
Company Secretary

Susan Ringdal             +44 20 7399 2760
Investor Relations Director

About Hikma

Hikma Pharmaceuticals PLC is a multinational pharmaceutical group focused on
developing, manufacturing and marketing a broad range of both branded and
non-branded generic and in-licensed pharmaceutical products. Hikma's operations
are conducted through three businesses: Generic, Branded and Injectable
Pharmaceuticals. Hikma's operations are based principally in the United States,
the Middle East and North Africa ("MENA") region and Europe. In 2006, the Group
had revenue of $317 million and profit attributable to shareholders of $54.5
million. For news and other information, please visit www.hikma.com.



                      This information is provided by RNS
            The company news service from the London Stock Exchange

END
RDSUORORBWRSRAR
Hikma Pharmaceuticals (LSE:HIK)
Historical Stock Chart
From Jun 2024 to Jul 2024 Click Here for more Hikma Pharmaceuticals Charts.
Hikma Pharmaceuticals (LSE:HIK)
Historical Stock Chart
From Jul 2023 to Jul 2024 Click Here for more Hikma Pharmaceuticals Charts.